The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.
Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…
While Mohs surgery has proven to be extremely effective at treating non-melanoma skin cancers like basal cell carcinoma and squamous cell carcinoma, there are huge drawbacks to the procedure from the perspective of the patient….
BOCA RATON, Fla., June 05, 2017 — Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced Joe…
The Greater Miami Chamber of Commerce has named medical device company Sensus Healthcare the most “disruptive” technology startup for 2017. Boca Raton-based Sensus Healthcare specializes in non-invasive tools aimed at treating skin conditions, such as…
BOCA RATON, Fla., May 24, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions, such as keloids with Superficial Radiotherapy…
